MSN MoneyCentral - Cougar Biotechnology, Inc. CGRB today announced that results from ongoing Phase I and Phase II clinical trials of Cougar's investigational drug, CB7630 (abiraterone acetate), were presented at the ASCO Genitourinary Cancers Symposium that is ...